SCHEMBL1502272

SCHEMBL1502272

C=CC(C(=O)O)N1CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 6/20 0.39
POLB P06746 3/20 0.37
KMT2A Q03164 3/20 0.37
TSHR P16473 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CYP3A4 P08684 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPK1 P28482 1/20 0.36
HIF1A Q16665 1/20 0.36
RAB9A P51151 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KCNA5 P22460 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10954945 0.81 LMNA (0.37) LMNA
SCHEMBL4450859 0.81 LMNA (0.41) ALDH1A1KMT2ATSHRMAPTSMN1; SMN2
SCHEMBL5523330 0.81 LMNA (0.41) ALDH1A1KMT2ATSHRMAPTSMN1; SMN2
SCHEMBL10408074 0.74 ALDH1A1 (0.31) ALDH1A1KMT2AMAPTSMN1; SMN2RAB9A
SCHEMBL6495037 0.72 ALDH1A1 (0.44) HSD17B10ALDH1A1POLBKMT2ATSHR
SCHEMBL10339146 0.72 ALDH1A1 (0.44) HSD17B10ALDH1A1POLBKMT2ATSHR
SCHEMBL14039979 0.71 RAB9A (0.55) HSD17B10ALDH1A1POLBKMT2ATSHR
SCHEMBL5171822 0.71 SMN1; SMN2 (0.37) HSD17B10ALDH1A1POLBKMT2ATSHR
SCHEMBL28687178 0.70 ALDH1A1 (0.42) HSD17B10ALDH1A1POLBKMT2ATSHR
SCHEMBL9620663 0.70 HSD17B10 (0.45) HSD17B10ALDH1A1POLBKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256114-B1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAINIPPON SUMITOMO PHARMA CO (JP) 2014-06-25 EP disclosed
US-7906510-B2 Amide derivative and pharmaceutical composition containing the same Dainippon Sumito Pharma Co., Ltd. (JP) 2011-03-15 US disclosed
EP-2256114-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Dainippon Sumitomo Pharma Co., Ltd. (JP) 2010-12-01 EP disclosed
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Sumitomo Pharma Co., Ltd. (JP) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249399-A1 AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME HTR4, MC2R, HTR1D HSD17B10 1608/4885ALDH1A1 2118/4885POLB 4784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.